drugset / Trial / NCT05489796

Bellomic PCA in Laparoscopic Gynecologic Surgery

NCT05489796

RandomizedParallel-groupQuadruple-blindTreatment

Summary

In laparoscopic gynecological surgery, when intravenous patient-controlled analgesia (IV-PCA) device is used after surgery, the degree of postoperative side effects and pain control is compared when a combination of fentanyl and ketorolac is administered compared to when fentanyl alone is used.

Timeline

Start
2022-06-30
Primary completion
2022-08-31
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 200 ug Intravenous
Subject Fentanyl Other / unclassified 700 ug Intravenous
Subject Ketorolac Other / unclassified 180 mg Intravenous

Indications

No indication recorded.